All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
News of Friday's FDA approval of Merck & Co. Inc.'s Victrelis as the first new hepatitis C drug in more than a decade is being overshadowed by the impending approval of the next in line, Vertex Pharmaceutical Inc.'s Incivek.